Ruxolitinib–ECP combination treatment for refractory severe chronic graft-versus-host disease
Kristina Maas‐Bauer, Chrissoula Kiote-Schmidt, Hartmut Bertz, Petya Apostolova, Ralph Wäsch, Gabriele Ihorst, Jürgen Finke, Robert Zeiser
Topics & Concepts
MedicineRuxolitinibCytopeniaSalvage therapyRefractory (planetary science)Graft-versus-host diseaseInternal medicineExtracorporeal PhotopheresisTransplantationGastroenterologyRetrospective cohort studySurgeryChemotherapyBone marrowMyelofibrosisPhysicsAstrobiologyHematopoietic Stem Cell TransplantationT-cell and B-cell ImmunologyImmune Cell Function and Interaction